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We sequenced the envelope (E) genes of 59 DEN-2 isolates collected from ten Caribbean islands, six South American countries, and two
Central American countries between 1981 and 2000, a period characterized by hyperendemicity and increased incidence of severe dengue.
Fifty-two isolates belonged to ‘‘American/Asian’’ subtype IIIb, possessing a characteristic polar residue at envelope aa position 390 (N [n =
48] or S [n = 4]) common to that group. Six isolates from Trinidad (1981), Honduras (1991 [4]), and El Salvador (1987) fell into the ‘‘Native
American’’ subtype V (D at aa 390), and one from Honduras (1986) belonged to ‘‘Asian’’ subtype I. The data suggest that after its first
isolation in the Caribbean in 1981, genotype IIIb spread throughout the Americas and effectively replaced subtype V throughout the
Caribbean basin. The strain also evolved into several distinct lineages, based on substitutions in the E glycoprotein (amino acids 91 and 131),
two of which were still in circulation in 2000. Interestingly, a molecular clock did not fit the data well, suggesting that other sources of rate
variation, such as differential selection or differences in effective population sizes, may exist among lineages. Our results indicate the
importance of large temporal- and geographical-scale phylogenetic studies in understanding disease dynamics, particularly where
replacements between regions can occur.
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Introduction diseases of the last century and one of the most seriousDengue viruses are mosquito-borne RNA viruses of the
family Flaviviridae. There are four closely related serotypes
(DEN-1–4) that are thought to represent at least three
independent introductions into humans from sylvatic pri-
mates, the most recent (DEN-1) occurring within the last
century (Wang et al., 2000). All four serotypes cause dengue
fever (DF), a relatively mild febrile illness, and in some
cases the potentially fatal dengue hemorrhagic fever (DHF)
and dengue shock syndrome (DSS). The broad distribution
of the mosquito vector Aedes aegypti in the tropics and
subtropics results in the exposure of approximately 2.5
billion individuals to dengue infection (WHO, 2002). Den-
gue is now one of the most important re-emergent infectious0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.03.020
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E-mail address: ccarrington@fms.uwi.tt (C.V.F. Carrington).health problems affecting tropical and subtropical regions of
the Americas (McBride and Bielefeldt-Ohmann, 2000).
Before the 1980s, outbreaks in the Americas were caused
by single serotypes and were geographically restricted and
generally self-limiting (Gubler, 1998). However, with
increases in global travel, uncontrolled population growth
and urbanization within the last 30 years, and the cessation
of regional mosquito control programs in the 1970s, epi-
demics have become steadily larger and more frequent with
increased numbers of DHF/DSS cases (Gubler, 2002; WHO,
2002). In fact, few cases of hemorrhagic manifestations
were reported until 1981 when the Americas experienced its
first major DHF/DSS epidemic (Gubler, 1997). Before this,
DEN-2 had been associated only with outbreaks of classic
DF for several decades (Gubler, 1997). The 1981 DHF/DSS
epidemic of DEN-2 was attributed to a strain imported from
Southeast Asia, where the severe form of the disease had
been endemic since the 1950s (Rico-Hesse et al., 1997).
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isolates collectively classified as subtype IIIb (Lewis et al.,
1993), and also referred to as the Asian–American subtype
(Rico-Hesse et al., 1997).
Although the onset of DHF/DSS in the Americas in 1981
was associated with the introduction of a novel strain of
DEN-2, changes in epidemic dengue severity have been
associated with hyperendemic transmission patterns (the co-
occurrence of multiple dengue serotypes in the same local-
ity) in other regions (Gubler, 1998). There is strong evi-
dence linking disease severity with secondary heterologous
infection (Halstead, 1988; Kliks et al., 1989; Thein et al.,
1997) and so increased hyperendemicity is likely to be one
of the most significant factors contributing to increases in
DHF/DSS (Gubler, 1997). By the early 1980s, all four
serotypes had been reported in the Caribbean basin
(CAREC, 2000) and the region experienced a rise in hyper-
endemicity, with two or more serotypes occasionally co-
occurring in the same outbreak (Campione-Piccardo et al.,
2003; Dietz et al., 1996).
The marked increase in the number of DHF cases in the
Caribbean, in the wake of the appearance of DEN-2 subtype
IIIb, has been largely attributed to the increased incidence of
secondary infections brought about by the co-arrivals of
DEN-1 and DEN-4 in 1977 and 1981, respectively (PAHO,
1979, 1981). However, the previously existing DEN-2 strain
in the region, termed the ‘‘Native American’’ strain and
classified as subtype V by Lewis et al. (1993), has never
been associated with DHF/DSS epidemics, despite evidence
of co-circulation with other serotypes (Gubler, 1997; Watts
et al., 1999). These and other data suggest that hyper-
endemicity may not be the only factor contributing to the
increased disease severity and that strain virulence may play
an important role (Cologna and Rico-Hesse, 2003; Endy et
al., 2002; Gubler et al., 1978; Leitmeyer et al., 1999;
Morens et al., 1991; Rico-Hesse, 1990; Rosen, 1977;
Sumarmo et al., 1983; Vaughn et al., 2000). In the case of
DEN-2 in the Americas, it appears that the Asian–American
strain is more virulent than its predecessor (Rico-Hesse et
al., 1997).
Of the four serotypes, DEN-2 has shown the most
genetic variability, reflected by its possession of the highest
number of subtypes described (Lewis et al., 1993; Rico-
Hesse et al., 1997). Given the epidemiological impact of the
introduced Asian–American strain and other evidence as-
sociating genetic change with shifts in the epidemic poten-
tial or pathogenicity of dengue virus serotypes and other
flaviviruses (Brault et al., 2002; Leitmeyer et al., 1999), it is
important to understand the pattern of genetic change that
has occurred in the Americas. Previous studies have shown
that change in dengue virus populations is associated in part
with introductions from both geographically and socioeco-
nomically related populations (Fong et al., 1998; Foster et
al., 2003; Lewis et al., 1993; Nogueira et al., 2000; Rico-
Hesse et al., 1997; Singh et al., 1999; Trent et al., 1983,
1989; Uzcategui et al., 2001). For example, in parts of theAmericas, the DEN-2 ‘‘Asian–American’’ subtype IIIb
appears to have displaced the ‘‘Native American’’ subtype
V (Rico-Hesse et al., 1997). However, the extent of this
proposed displacement is not clear and subsequent phylo-
genetic studies on DEN-2 in the Americas have been
restricted to individual countries (Dos Santos et al., 2002;
Halstead et al., 2001; Nogueira et al., 2000; Ruiz et al.,
2000; Sariol et al., 1999; Tolou et al., 2000; Uzcategui et al.,
2001), so that we have an incomplete understanding of the
subtypes’ evolution since the introduction. Here we consider
the phylogenetic relationships between DEN-2 isolates from
throughout the Caribbean basin and neighboring territories
in South and Central America (Fig. 1) collected over the 20
years following the arrival of the Asian–American strain in
1981 to assess the pattern of genetic change in DEN-2
across a region of potentially distinct populations marked by
changing disease dynamics. An understanding of the links
between evolution, gene flow, and selection should ulti-
mately make it possible to identify those viral lineages that
are most likely to spread and seed new epidemics, and in
what way they are most likely to spread regionally.
In reporting our results, we use several terms that appear
in both evolutionary biology and virology literature, but are
not always used in the same sense. ‘‘Genotype’’ is used in
its traditional genetic sense to refer to the unique sequence
of bases possessed by a single isolate (we also may refer to
such an individual as a ‘‘variant’’). Each isolate is actually a
sample of multiple and potentially variable virus particles
within the host (Wang et al., 2002) presumably representing
the most common genotype present. Indeed, sequence poly-
morphism(s), indicating the presence of multiple and equal-
ly common genotypes and virions within a single sample,
was never observed in our samples. Virological nomencla-
ture often uses the term ‘‘genotype’’ to refer to a class of
similar (but not identical) isolates. Instead, we use the term
‘‘lineage’’ to describe groups of similar, and presumably
related individuals that share a common ancestor (mono-
phyletic), when that relationship is supported at least 75% of
the time by bootstrap analysis. The term ‘‘gene flow’’ is
used to refer to the movement and establishment of viral
genes, and thus dengue viruses, among populations (i.e.,
populations of viruses in their populations of hosts). Finally,
in our phylogenetic analyses, we consider genetic changes at
both the base pair and amino acid level, because the former
does not always result in the latter.Results
Examination of evolutionary relationships among DEN-
2 samples from around the world (Fig. 2) indicated that 46
out of 47 Caribbean island isolates (representing 27 unique
country and year combinations) and all 17 of our South
American isolates (representing eight unique country and
year combinations) fell into a single well-defined lineage
that has previously been described as subtype IIIb (Lewis
Fig. 1. Map showing countries in the Americas represented in this study. Countries represented in each region are numbered and colored to distinguish them
from surrounding territories. (A) Caribbean islands—the Bahamas (labeled 1) and the Greater Antilles (Dominican Republic and Puerto Rico; labeled 2 and 3,
respectively); the Dutch Antilles (Aruba, Curacao; labeled 4 and 5), and the Lesser Antilles (Barbados, Dominica, Grenada St Lucia, St. Vincent, and Trinidad
and Tobago; labeled 6–11, respectively). (B) Central America—El Salvador and Honduras (labeled 12 and 13, respectively). (C) South America—Bolivia,
Colombia, Ecuador, Guyana, Suriname, and Venezuela (labeled 14–19, respectively).
Table 1
Amino acid changes within the E glycoprotein of DEN-2 subtypes and
lineages in study
Phylogeny Amino acid at E gene position
Subtype Group/lineage 91 129 131 390 485
IIIb Clade 1 L V L N V
Clade 2 V V L N V
Clade 3 I V Q N V
Clade 4 I V L N V
Asian V I Q N I/L
V – V I Q D V
I – V V Q N V
J.E. Foster et al. / Virology 324 (2004) 48–5950et al., 1993). Nucleotide sequences within this lineage
differed by 0.1–3.6%. All but four of the subtype IIIb
isolates examined shared an asparagine (N) at amino acid
position 390, in contrast to aspartic acid (D) (the derived
state with respect to the global DEN-2 phylogeny), which
distinguishes the Native American subtype V (Table 1).
Although both of these amino acids are polar, the former is
uncharged and the latter negatively charged. Four of our
subtype IIIb isolates, all Trinidadian (TRI 1987, TRI 1988,
TRI 1989 and TRI 1996 A; Fig. 3, clade 1), shared an
alternative substitution of serine (S) at position 390, which
has been previously reported in isolates of the ‘‘Cosmo-
politan’’ subtype IV (Twiddy et al., 2002a, 2002b). Like N,
S is a polar and uncharged residue.
The sole Caribbean isolate that did not fall within
subtype IIIb was a 1981 isolate from Trinidad (TRI
1981), which belonged to Native American subtype V
(Fig. 2). This group also contained earlier Caribbeanisolates from Puerto Rico (1969) and Trinidad (1953),
along with five Central American isolates: four from
Honduras (1991) and one from El Salvador (1987)
(HON 1991 A–D, SAL 1987; Fig. 2, subtype V). All
possessed D at amino acid position 390, characteristic of
Fig. 2. Neighbor-joining tree of Global DEN-2 isolates. Neighbor-joining tree of globally distributed DEN-2 based on 1404-bp sequences of 93 isolates. DEN-
2 subtypes 1–5, as described by Lewis et al. (1993), are labeled I, II, III, IV, and V, respectively. American isolates from this study falling outside subtype IIIb
are labeled as follow, Honduras (HON), El Salvador (SAL), Trinidad (TRI). Remainder of global sequences in subtypes 1, 2, 4, and 5 obtained from PubMed
database.
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Central American isolate in our study, from Honduras
(1986), fell into subtype I, and was closely related to the
New Guinea C prototype strain (Fig. 2).
Subtype IIIb is comprised of an exclusively American
clade, basal to which occur three Asian representatives of
the subtype (THAI D89-828, CHI 1985, and VIE 1997;
Fig. 3, labeled A). The American isolates differed from
their Asian counterparts at positions 129 and 485 of theenvelope protein: All American isolates have valine (V) at
both positions, while Asian isolates have isoleucine (I) at
position 129, and either I (CHI 1985, VIE 1997) or leucine
(L, THAI D89-828) at position 485 (Table 1). All three of
these amino acids have similar properties. In addition,
Asian subtype IIIb isolates all bear the ancestral state at
amino acid positions 91 and 131 of V and glutamine (Q),
respectively, whereas American isolates, although poly-
morphic overall for these positions (I, L, or V at position
Fig. 3. Maximum likelihood tree of DEN-2 subtype IIIb. Maximum-likelihood tree of DEN-2 based on 1404-bp sequences of 71 isolates from around the
Caribbean, Central and South America (1981–2000). Bootstrap support values were generated using 1000 replicate neighbor-joining trees reconstructed under
the ML substitution model (Posada and Crandall, 1998). The names of isolates refer to country of origin and year of isolation. In cases where there is more than
one isolate from a given country and year, a unique isolate number (and/or letter or code) is also indicated. American countries represented are Aruba (ARU),
Brazil (BRA), Bahamas (BAH), Barbados (BDS), Bolivia (BOL), China (CHI), Colombia (COL), Curacao (CUR), Dominica (DOM), Dominican Republic
(DR), Ecuador (EC), Grenada (GRE), Guyana (GUY), Jamaica (JAM), Puerto Rico (PR), Martinique (MAR), Mexico (MEX), St. Lucia (ATL), St. Vincent
(STV), Suriname (SUR), Thailand (THAI), Trinidad and Tobago (TRI), Venezuela (VEN), Vietnam (VIE). Scale represents number of nucleotide substitutions.
Sequences for BRA 1990, JAM 1981, VEN 1999, VEN 2000, MAR 1998, CHI 1985, THAI D89 828, and VIET 1997 were obtained from the PubMed
database. Lineages are numbered 1–4, respectively. Black bars along the root branch represent amino acid changes between American and Asian subtype IIIb
isolates at positions 91, 129, 131, and 485. Another black bar along the branch leading to Trinidadian subclade of clade 1 represents a reversion to the ancestral
state at amino acid position 390. Colored bars along branches represent amino acid changes amongst American DEN-2 subtype IIIb lineages: L ! V at
position 91 (red), L ! I at position 91(blue), and L ! Q at position 131 (green).
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underwent initial substitutions at both sites for L (Fig. 3).
We found no evidence for recombination within the E
gene of any of the DEN-2 isolates included in this study.
Split decomposition plots showed no recombinant sequen-
ces (data not shown), nor did analyses using PIST on either
data set: Our estimate of the proportion of 2-state parsimo-
ny-informative changes in our ML trees (relative to all
polymorphic sites), q, was 0.71 for the global data set and
0.55 for the subtype IIIb subset, neither significantly differ-
ent from estimates from sequences evolved under clonality,
qˆc, of 0.69 [ p( q = qˆc) = 0.26] and 0.53 [ p( q = qˆc) = 0.34],
respectively.
Since the introduction of subtype IIIb into the Caribbean
in 1981 (represented by JAM 1981), American isolates of
DEN-2 subtype IIIb have formed four major well-supported
clades (labeled 1–4 in Fig. 3). These clades are defined
primarily by time period of isolation (with some overlap)
and to a lesser extent by geography, with the exception of an
almost exclusive Puerto Rican clade (clade 2, Fig. 3). Clade
1 consists largely of mid to late 1980s isolates from the
Lesser Antilles (Barbados and Trinidad) and Suriname (Fig.
3). This clade has complete amino acid homology with the
JAM 1981 isolate and is defined only by four silent
mutations over the gene region examined, with the excep-
tion of the Trinidadian subclade already mentioned that
nests within clade 1. Clade 2 consists of mid to late 1980s
and early 1990s isolates from Puerto Rico, along with a
1993 Colombian isolate (Fig. 3). This group is distinguished
from the introduction isolate by an L ! V change at aa
position 91 and two silent mutations. Clade 3 consists of
early to late 1990s isolates from north-coastal South Amer-
ica (Venezuela and Suriname) associated primarily with
isolates from those Caribbean islands closest to the South
American mainland (i.e., Aruba, Curacao, and Trinidad)
(Fig. 3). This clade is distinguished by five silent mutations
and amino acid substitutions at envelope positions 91 (L to
I) and 131 (L to glutamine, Q), the latter shared by two other
weakly associated isolates (PR 1986 B and DR 1990; Fig.Table 2
Likelihood ratio test for different models of sequence evolution in dengue subtyp
Data type Model lnL AIC P
Full codon DR 4271.97 8821.94 1
VRDT 4345.95 8835.89
SRDT 4349.11 8840.21
SR 4418.70 8977.4075
Third codon DR 2158.71 4595.41 1
VRDT 2211.25 4566.49
SRDT 2213.37 4568.74
SR 2279.16 4698.323). At the base of clade 3 is a 1989 Bahamian isolate (BAH
1989) that may have ‘‘seeded’’ the lineage. Clade 4 is
comprised of late 1990s to 2000 isolates from the Lesser
Antilles island chain (Barbados, Dominica, Grenada, St.
Lucia, St. Vincent, and Trinidad), along with a lone South
American isolate from Guyana (Fig. 3). This group may
have arisen as early as 1995 in Dominica (Fig. 3, clade 4A;
DOM 1995 A and DOM 1995 B). Clade 4 is distinguished
by eight silent changes in addition to an amino acid
substitution at position 91 (L to I). It shares this amino acid
change with various weakly associated Greater Antilles
isolates from the same time period (PR 1998 A and PR
1998 B) or earlier (DR 1984) and South American isolates
from Brazil (1990), Bolivia (1997), Ecuador (2000), and
Venezuela (1990) (Fig. 3, branch with bootstrap of 69%;
Table 1). In addition, there were a number of isolates from
around the Caribbean basin dating from 1983 to 1990 that
did not group within clear phylogenetic lineages (see Fig. 3;
JAM 1983, PR 1986 B, SUR 1986 A–C, DR 1990).
Although subtype IIIb is somewhat both temporally and
geographically ordered, there are several instances in which
isolates from the identical time and place fall into separate
clades, representing the co-circulation of multiple dissimilar
genotypes. For example, two Trinidad isolates from 1996
occur in clade 1 and 3, respectively; and isolates from
Dominica recovered in 1995 are associated with both clades
3 and 4, one of which appears to represent the origin of the
latter.
There was considerable variation in rate of molecular
change across our subtype IIIb phylogeny and the differen-
tial rates (DR) model of molecular evolution provided by far
the best fit even after applying the Dunn–Sida´k correction
for multiple tests (data not shown). Analysis of third codon
positions also did not support a molecular clock for the
subtype IIIb data set according to uncorrected and corrected
likelihood ratio tests, although according to the minimum
Akaike information criteria (AIC; Akaike, 1974), VRDT and
SRDT clock-like models outperformed DR (Table 2). Using
the full codon data set, we estimated an absolute rate ofe IIIb
arameters LRT df P(v2)
39 – – –
72 VRDT vs. DR 67 4.83  108
71 SRDT vs. DR 68 1.19  108
SRDT vs. VRDT 1 1.19  102
70 SR vs. DR 69 1.83  1029
SR vs. VRDT 2 2.53  1032
SR vs. SRDT 1 3.99  1032
39 – – –
72 VRDT vs. DR 67 2.04  103
71 SRDT vs. DR 68 1.1  103
SRDT vs. VRDT 1 3.94  102
70 SR vs. DR 69 6.79  1021
SR vs. VRDT 2 3.21  1030
SR vs. SRDT 1 1.85  1030
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model of evolution of 5.66  104 substitutions per site per
year (confidence intervals of 4.26  104 and 7.20  104
substitutions per site per year). According to this model, the
estimate for subtype IIIb’s most recent common ancestor
(MRCA) was 33.31 years (with confidence intervals of 29.66
and 39.41 years) before the year 2000.Discussion
This is the first large-scale regional analysis of DEN-2
populations in the Caribbean since the introduction of the
Asian–American DEN-2 strain and the onset of epidemic
DHF/DSS in 1981. Our samples were drawn from countries
around the Caribbean Sea, as well as greater South and
Central America. The data indicate that subtype IIIb spread
throughout the Americas by the early to mid 1980s, and
over the past 20 years has evolved into at least four lineages,
only two of which were still in circulation up to 2000. The
most recent Native American (subtype V) isolate we
detected in the Caribbean islands was from Trinidad
(1981). The absence of this subtype beyond that year
suggests that, at least within this part of the Americas, it
has been displaced by the Asian–American strain, a theory
first proposed by Rico-Hesse et al. (1997). However, given
that we detected subtype V in El Salvador in 1987 and as
recently as 1991 in Honduras, this strain may still persist in
Central America. Likewise, although all of the South
American isolates in our study belonged to subtype IIIb,
Watts et al. (1999) confirmed the presence of subtype V in
Iquitos, Peru as late as 1996 and suggested that this strain
also persists in isolated pockets of South America. It is also
important to consider the fact that the CAREC and CDC
collections from which our isolates were derived are likely
to be more representative of symptomatic than asymptom-
atic cases (see Materials and methods). Although both
subtypes are associated with symptomatic disease, subtype
V is thought to be less virulent than subtype IIIb (Rico-
Hesse et al., 1997), so the apparent absence of subtype V
among our isolates may also be a result of sample selection.
The presence of a New Guinea C-like strain in Honduras
in 1986 (see Fig. 2; subtype I) was unexpected, because this
subtype of DEN-2 has not been observed in the Americas in
the last half of the century. Only two previous American
studies (Halstead et al., 2001; Rico-Hesse et al., 1997) have
identified isolates similar to this NGC-44 strain, from
Venezuela (1994 and 1995), Mexico (1995), and more
recently Haiti (2001). However, given that NGC-44 is one
of the most commonly used dengue virus laboratory and
reference strains, it is also plausible that isolates of this
strain identified in the Caribbean may be laboratory con-
taminants. Based on our estimates of evolutionary rate, we
would expect a 1986 isolate to differ from a 1944 strain by
approximately 0.018% (conservative lower bound rate esti-
mate 4.26  104 substitutions per site per year  42years = 0.018 substitutions per site). In fact, they differ by
<0.005%, suggesting their origins are not 42 years apart
and that the identity of the Honduran 1986 sample is
erroneous.
While fluctuations in clock-like behavior increase the
error in rate estimations, Jenkins et al. (2002) have shown
that substitution rates estimated on large data sets are still
reliable indicators of the average speed of evolution even
when there is rate heterogeneity. Therefore, in spite of
differential evolutionary rates among DEN-2 Caribbean
subtype IIIb lineages, we estimated a single evolutionary
rate across the phylogeny based on the SRDT model (5.66 
104 substitutions per site per year) (confidence intervals of
4.26 104 and 7.20 104 substitutions per site per year).
This estimate is comparable to rates reported in previous
studies on DEN-2 subtypes (Twiddy et al., 2003; Wang et al.,
2000). According to this rate, the estimate for subtype IIIb’s
most recent common ancestor (MRCA) was 33.31 years
(with confidence intervals of 29.66 and 39.41 years) before
the year 2000. Again similar similar to estimates for other
DEN-2 subtypes of Asian origin (Twiddy et al., 2003) and
corresponds to the post WWII period when dengue began its
resurgence in Southeast Asia and the Pacific (Gubler, 1997),
where the Asian–American strain is thought to have origi-
nated.
Since subtype IIIb was first introduced into the our study
area in the early 1980s, its evolution has involved repeated
substitutions over few amino acid positions in the E gene,
suggestive of positive selection acting on these sites. This is
in contrast to parallel studies of DEN-4 evolution in the
Caribbean, which found little evolutionary activity in the E
gene (Bennett et al., 2003; Foster et al., 2003). Three of the
four major clades within subtype IIIb (clades 2, 3, and 4) are
defined by amino acid mutations at a single position (91). In
the case of clade 2 the L ! V change at position 91 may
represent reversion to the ancestral state, because this amino
acid is present in sylvatic strains (Wang et al., 2000) and
Asian members of the subtype (see Table 1; Blok et al.,
1989). The L ! I change at the same position that defines
clades 3 and 4 is found only in our American isolates dated
after 1988 and in Venezuelan isolates from the 1990s
(Uzcategui et al., 2001). However, all substitutions we
observed at position 91 involved amino acids with very
similar properties. Only the additional substitution defining
clade 3, a character state it shares with two immediately
basal isolates and the Asian members of subtype IIIb, is
likely to represent a significant phenotypic change. This
substitution (which again appears to represent a reversion to
the ancestral state) involved a replacement at aa residue 131
by an amino acid with different properties, where Q, a polar,
hydrogen bond-forming residue, replaced L, a hydrophobic
one. Position 131 resides in domain II of the flavivirus
envelope glycoprotein model put forth by Rey et al. (1995).
The impact of the substitution, if any, is presently unknown
but since domain II is involved in virus-mediated fusion,
mutations here may affect this function by disrupting the
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1994; Twiddy et al., 2002a, 2002).
The temporal progression of clades within subtype IIIb
suggests a complex interaction of evolutionary forces acting
on DEN-2 (e.g., selection, genetic drift, and gene flow).
Some subtype IIIb lineages appear to have been more
successful than others. Clades 3 and 4 appear to have
remained in circulation throughout the Americas up to the
year 2000 while the most recent isolates in clades 1 and 2
are from the mid 1990s, suggesting that these lineages are
extinct. The two persistent clades are comprised mainly of
isolates dated 1993–2000. However, both lineages contain
at least one isolate from the late 1980s to early 1990s (BAH
1989 in clade 3; DOM 1995 A, and B in clade 4),
suggesting that they originated from isolates co-circulating
with the older clades. Positive selection could account for
differential success among clades: Although recent studies
have provided no strong evidence for this in the dengue
virus E gene (Bennett et al., 2003; Twiddy et al., 2002a,
2002b), nonstructural genes which we did not survey, are
also targets for selection in dengue viruses (Bennett et al.,
2003; Leitmeyer et al., 1999; Twiddy et al., 2002a, 2002b).
Alternatively, local population dynamics leading to genetic
bottlenecks could have randomly led to extinction and
replacement of clades 1 and 2 by 3 and 4 through genetic
drift. Gene flow between regions becomes an important
mechanism for introducing dengue variants and establishing
new lineages in a given locality, especially under such
conditions.
The movement of viral variants (gene flow) between
regions within the Caribbean basin and South and Central
America is facilitated by geographic proximity, and cultural
and economic ties. Based on its phylogeography (Fig. 3),
DEN-2 subtype IIIb spread across the region after its
introduction in 1981 in a manner suggesting established
DEN transmission routes between the Caribbean islands and
north-coastal South America. For example, although most
isolates from the coast of South America bordering the
Caribbean Sea, such as those from Suriname and Venezuela,
grouped together into clade 3, this cluster also included
isolates from nearby territories such as Trinidad, Aruba, and
Curacao (Fig. 2, clade 3) rather than those from the Pacific
coast of the continent such as Ecuador. Similarly, all of the
1990s isolates from the Lesser Antilles formed a close-knit
group (Fig. 3, clade 4), which also included an isolate from
nearby Guyana from the same time period (GUY 2000).
Venezuela, Suriname, and Guyana represent obvious transit
points for viruses travelling between the Caribbean islands
and the mainland: Venezuela because of its close proximity
(Aruba, Curacao and Trinidad, the southernmost Caribbean
island, are within 56 km of Venezuela’s shores); Suriname
and Guyana because of their relative proximity and strong
socioeconomic links from membership in the Caribbean
Common Market (CARICOM). Similar geographic and
socioeconomic relationships have been observed among
DEN-4 populations in the Caribbean basin, which exhibithigher degrees of gene flow correlated with less divergence
among Antillian and South American populations bordering
the Caribbean Sea, relative to populations from Central
America and Ecuador (Foster et al., 2003).
In contrast, the Greater Antilles appear to act as an
evolutionarily independent DEN-2 population with gene
flow restricted to member islands and only the occasional
exchange of variants beyond. Puerto Rican isolates from the
late 1980s to mid-1990s formed an independent clade (clade
2) that included only a single non-Puerto Rican isolate from
Colombia (COL, 1993). Late 1990s, Puerto Rico isolates
grouped with Dominican Republic isolates although they
were separated by 14 years (84% bootstrap support, Fig. 3).
Puerto Rico has a large dense urban population (in contrast
to smaller islands in the Lesser Antilles) with high mosquito
vector densities (Bennett et al., 2003). The island therefore
has the capacity to act as a center of high viral diversity in
its own right, viral lineages being less susceptible to
extinction and recolonization from other populations and
more likely to appear phylogenetically distinct (Bennett et
al., 2003). The phylogenetic association of isolates from
Puerto Rico with those from Colombia and the Dominican
Republic may reflect a ‘‘Latin American’’ transmission
route based on cultural and economic ties between these
Spanish-speaking territories, presumably stronger than ties
to the Lesser Antilles and other non-Spanish speaking
regions. The phylogenetic association of the Bahamas
isolate supports this pattern, because although derived from
a Greater Antillean island, it instead shares a common
phylogenetic history with clade 3, the north-coastal South
American/southern Caribbean clade. This association sug-
gests that the 1989 Bahamas isolate seeded clade 3, and
reflects strong cultural (English-speaking) and economic
(through CARICOM) links between the Bahamas and the
Lesser Antilles.
The complexity of DEN-2 subtype IIIb evolutionary
history in the Americas is further indicated by differences
in evolutionary rates acting on each lineage of the phylog-
eny. In our analyses, the differential rates (DR) model for
evolution significantly outperformed models that estimate a
single or linearly changing rate for all lineages (i.e., SRDT
and VRDT models, respectively), both for full codon and
third codon position subset of subtype IIIb. In contrast,
another recent study of molecular evolution in DEN-2 found
that a molecular clock did fit (Twiddy et al., 2003). Differ-
ences in evolutionary rates across branches of a phylogeny
could be due to selection (as discussed above) or lineage-
specific demographic properties. Differences in viral popu-
lation dynamics, particularly fluctuations in viral effective
population size among regions, could create variation in
both neutral and non-neutral evolutionary rates (Gillespie,
1999; Ohta, 2002). Indeed, the phylogenetic and epidemi-
ological patterns suggest that DEN-2 populations in the
Caribbean are best described as a series of loosely
interconnected source and sink populations (i.e., a metapo-
pulation; Gilpin and Hanski, 1991). Disease dynamics
J.E. Foster et al. / Virology 324 (2004) 48–5956among DEN populations differ depending on a number of
extrinsic factors including host population sizes and im-
mune history, vector habitat and control efforts, rainfall, and
temperature (Gratz, 1999; Gubler, 1993; Kuno, 1997;
WHO, 2002). The semi-independent nature of dengue viral
populations is also reflected in a history of disjunct out-
breaks across the region, lagging between locations by one
to several years (Gubler, 1993). Furthermore, it is unlikely
that all DEN-2 populations within the Caribbean basin are at
evolutionary equilibrium (easily disrupted by bottlenecks),
and this could also lead to extensive rate variation (Ohta and
Gillespie, 1996). Markedly unstable, dengue populations
fluctuate between very large sizes during epidemics and
periods of extremely small population sizes leading in some
instances to local extinction (Kuno, 1997; Sittisombut et al.,
1997). Even on large islands like Puerto Rico, which sustain
continuous dengue transmission, effective population size
(sensitive to the lowest extreme) is on the order of 500
viruses during epidemic periods where up to an estimated
850,000 people could have been infected (Bennett et al.,
2003).
In conclusion, our large regional and temporal scale
phylogenetic study suggests that DEN-2 in the Caribbean
basin including parts of South America is primarily subtype
IIIb, displacing the former subtype over a wide geographic
area since its introduction in 1981. The phylogeographic
pattern of subtype IIIb evolution underscores the absence of
physical barriers to DEN transmission among territories
within the Caribbean basin and emphasizes the need for
dengue control efforts that focus on a regional rather than
local scale (Foster et al., 2003). The temporal progression of
clade evolution within subtype IIIb and observed variationTable 3
Country, year of isolation, and number of DEN-2 isolates sequenced in this study
Country of isolation Year of isolation
1981 1983 1984 1986 1987 1988 1989 19
Aruba
Bahamas 1
Barbados 1 1
Bolivia
Colombia
Curacao
Dominica
Dominican Republic 1 1
Ecuador
El Salvador 1
Grenada
Guyana
Honduras 1
Jamaicaa 1
Puerto Ricoa 2 2
St. Lucia
St. Vincent
Suriname 4
Trinidad 1 4 1 1 1
Venezuela 1
a Bennett et al., unpublished data.in rates of molecular evolution suggest the presence of
complex evolutionary dynamics throughout its history. Fur-
ther work is needed to determine what factors have dictated
the success or failure of individual lineages, and to deter-
mine whether the phylogenetic diversity observed translates
into differences in virulence and transmittability.Materials and methods
Viral archive, RNA extraction, and RT-PCR
Virus isolates were obtained from the Caribbean Epide-
miology Centre (CAREC), Trinidad, and the Centers for
Disease Control and Prevention (CDC), Dengue Branch,
San Juan, Puerto Rico. At both institutions, viruses were
isolated from sera and, if necessary, cultured in C6/36
mosquito cells. These institutions are principal sources of
dengue identification and serotyping in the Caribbean basin
and regularly receive sera from medical institutions through-
out the Americas. The samples received therefore usually
represent symptomatic infections. We randomly selected
viruses from the collections, stratified to represent the
multiple localities and years in which DEN-2 has been
recorded between 1981 and 2000. In total, we sequenced
59 isolates from 10 Caribbean islands (n = 36), 6 South
American countries (n = 17), and 2 Central American
countries (n = 6). Table 3 shows the year, country of origin,
and number of isolates included in this study.
Viral RNA was extracted from sera or cell culture
supernatant using QIAamp Viral RNA Mini kits (Qiagen
GmbH, Germany) according to the manufacturer’s instruc-90 1991 1993 1994 1995 1996 1997 1998 1999 2000
1
1
1
1
1 1
3
2
1
1
4
2 2 2
4
4
4 3
2 3 2
J.E. Foster et al. / Virology 324 (2004) 48–59 57tions. For each isolate, we amplified a 1404-bp region of the
genome encoding almost the entire 1485-bp envelope (E)
gene in reverse transcriptase-polymerase chain reactions
(RT-PCRs). RT-PCR amplification primer sequences are
provided in Table 4. Where necessary, RT-PCR products
were purified before sequencing using Qiagen PCR purifi-
cation kits (Qiagen), as outlined by the manufacturer.
RT-PCR fragment sequencing
Cycle-sequencing reactions were performed using Taq
DyeDeoxy Terminator Cycle Sequencing Kits (Applied
Biosystems, Foster City, CA), according to the manufactur-
er’s instructions, with sequencing primers described in Table
4. Products were cleaned by standard precipitation before
sequencing on an ABI PRISM 377 automated DNA se-
quencer (Applied Biosystems). Sequences were then aligned
against a DEN-2 reference sequence (Irie et al., 1989)
(GenBank number M29095) and fragments combined for
a given isolate using Sequencher 3.1.1 software (Gene
Codes, Michigan) to obtain a continuous nucleotide se-
quence for each sample. All sequences generated in this
study can be accessed in GenBank (accession numbers
AY484598–AY484667).
Phylogenetic analysis
Sequences were aligned using MEGALIGN v 3.1.7
(Lasergene), employing the Clustal algorithm (Higgins and
Sharp, 1988; Higgins et al., 1996) and the alignments
manually checked for errors. Two phylogenetic trees were
then constructed using PAUP 4.0b10 (Swofford, 1998). In
the first, all 59 sequences were compared with 11 unpub-
lished sequences (2 Jamaican, 9 Puerto Rican; Bennett et al.,
manuscript in preparation) and 21 previously published
sequences (representing all five DEN-2 subtypes) in a
neighbor-joining tree, as a means of subtyping our samples.
For all sequences falling into the DEN-2 subtype IIIb clade
(n = 71 including eight reference sequences (L10041,
M15075, AF119661, AF195041, AF208496, AF398108,
AF398114, AF410358), we then constructed a second tree
derived by maximum likelihood for a more rigorous assess-Table 4
List of primers used to amplify and sequence envelope of DEN-2
Primera Sequence
U1019 5V-AACATGGAAGTTGTGTGACGACGAT
L2526 5V-TTTGAAGGGGATTCTGGTTGGAAC
U1027 5V-AGTTGTGTGACGACGATGGCAAAAA
L1405 5V-TGATTTCCTTGCCATGTTTTCCTGT
U1417 5V-GGCAAGGAAATCAAAATAACACCAC
U1736 5V-CAGGGGCCACAGAAATCCAGATGTC
L1776 5V-CCTGCACTTGAGATGTCCTGTGAAC
L2131 5V-TTGTCTCAAACATTTGGCCGATGGA
U2149 5V-GAGACAACAATGAGAGGAGCGAAGA
L2476 5V-CGTTATCTGTGATGAAGATCCCGCT
a Designed by Bennett et al.ment of the subtype’s microevolution. Tree calculations were
based on models of sequence evolution whose parameters
were estimated by maximum likelihood, using Modeltest
3.06 PPC (Posada and Crandall, 1998). The resultant phy-
logenetic tree was rooted with a subgroup of Asian isolates
belonging to subtype III that served as an outgroup against
which to compare our Caribbean isolates. We assessed the
reliability of the tree topology by bootstrapping the data set
1000 times to generate neighbor-joining trees. Internal nodes
of particular interest are labeled with percent times obtained,
if greater than 50. We denote groups as ‘‘well-supported’’ if
their bootstrap values are at least 75% (this value was
arbitrarily selected because it is midway between 50 and
100). Initial recombination analysis was performed on the
data by comparing neighbor-joining trees based on 500
continuous bases at a time for topological incongruities.
SplitsTree v2.4 (Huson, 1998) was also used at this stage
to examine sequences for recombination by way of the split
decomposition method, which produces network-like trees
when recombination is present in data sets. Finally, we
assessed the overall degree of recombination among our
DEN-2 isolates’ E gene sequences using PIST 1.0 (Worobey,
2001) on both data sets (i.e., the global DEN-2 data set and
the DEN-2 subtype IIIb subset). This method assesses the
maximum-likelihood tree for elevated proportions of two-
state parsimony-informative polymorphic sites, by compar-
ing this index to the number of such sites observed over 1000
simulations of clonal evolution (constrained to the same tree
and model of evolution; Worobey, 2001).
Finally, to estimate the rate of evolution within subtype
IIIb and/or detect differences in these rates over time and/or
across lineages, we compared the fit of different models of
evolutionary rates, using hierarchical likelihood ratio tests
(Rambaut, 2000) and Akaike Information Criteria (AIC)
(Posada and Crandall, 1998). Models of substitution rate
include a non-clock-like rate of evolution indicated by
different rates for each branch (DR model), and three
clock-like models of evolution given by a rate for all
branches that varies linearly over time (VRDT), a single
rate for all branches, with noncontemporaneous tips
(SRDT), and a single rate for all branches where tips are
constrained to be contemporaneous (SR; estimated byFunction Genome position
amplification 1019
amplification 2526
sequencing 1027
sequencing 1405
sequencing 1417
sequencing 1736
sequencing 1776
sequencing 2131
sequencing 2149
sequencing 2476
J.E. Foster et al. / Virology 324 (2004) 48–5958enforcing a molecular clock in PAUP* with no consider-
ation for noncontemporaneous samples). Likelihood scores
for each model were generated in TipDate version 1.2
(Rambaut, 2000), along with a maximum-likelihood esti-
mate of substitution rates and 95% confidence intervals for
the rooted ML tree (Rambaut, 2000). Confidence intervals
were estimated on a reduced, representative data set of 20
isolates, due to computational constraints. All calculations
were performed using the REV six-parameter nucleotide
substitution model (Lanave et al., 1984; Rodriguez et al.,
1990), the best-fitting model for our data set according to
Modeltest 3.06 PPC (Posada and Crandall, 1998).Acknowledgments
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